|
UBE2F expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.965780E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.797820E-01 |
| Normal-vs-Stage2 |
7.532200E-01 |
| Normal-vs-Stage3 |
4.399600E-01 |
| Normal-vs-Stage4 |
7.465400E-01 |
| Stage1-vs-Stage2 |
4.969400E-01 |
| Stage1-vs-Stage3 |
4.593600E-01 |
| Stage1-vs-Stage4 |
3.575000E-01 |
| Stage2-vs-Stage3 |
8.180600E-01 |
| Stage2-vs-Stage4 |
9.618200E-01 |
| Stage3-vs-Stage4 |
7.156600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.468600E-01 |
| Normal-vs-AfricanAmerican |
1.622590E-01 |
| Normal-vs-Asian |
2.992400E-01 |
| Caucasian-vs-AfricanAmerican |
4.218800E-01 |
| Caucasian-vs-Asian |
7.817400E-01 |
| AfricanAmerican-vs-Asian |
5.920000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.817000E-01 |
| Normal-vs-Female |
2.054000E-01 |
| Male-vs-Female |
3.594200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.376000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.325570E-01 |
| Normal-vs-Age(61-80Yrs) |
6.629600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.495600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.059400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.274800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.592800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.065600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.782400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.178000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.635600E-01 |
| Classical-VS-Follicular |
4.566100E-02 |
| Classical-VS-Other |
5.327800E-01 |
| Classical-VS-Normal |
9.223600E-02 |
| Tall-VS-Follicular |
2.460800E-01 |
| Tall-VS-Other |
6.317000E-01 |
| Tall-VS-Normal |
3.523400E-01 |
| Follicular-VS-Other |
8.872800E-01 |
| Follicular-VS-Normal |
7.963600E-01 |
| Other-VS-Normal |
8.445800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.393600E-01 |
| Normal-vs-N1 |
6.845800E-01 |
| N0-vs-N1 |
1.660160E-01 |
|
|
